Florida Cancer Specialists & Research Institute, LLC

Florida Cancer Specialists & Research Institute (FCS) is a leading provider of community-based oncology and hematology services, dedicated to delivering world-class cancer care close to home. Headquartered in Fort Myers, Florida, the organization focuses on compassionate patient care, innovative clinical research, and the application of cutting-edge technologies and treatments.

FCS offers a comprehensive range of services including medical oncology, hematology, radiation oncology, pathology, and diagnostic imaging. A key differentiator is its robust clinical research program, providing patients access to more clinical trials than any other private oncology practice in Florida, often leading the nation in initiating studies for groundbreaking therapies. The institute also provides genomic-based treatments, immunotherapy, and a specialty pharmacy service (Rx To Go), alongside various patient support services.

As the largest independent medical oncology/hematology practice in the United States, FCS operates nearly 100 locations across Florida. In a significant development, McKesson Corporation acquired a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), an administrative services organization established by FCS, in 2025. While FCS physicians retained a 30% interest in Core Ventures and FCS itself remains independently owned, it has joined McKesson's The US Oncology Network. The leadership team includes President & Managing Physician Dr. Lucio N. Gordan and CEO Ryan Ciarrocchi.